The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Open accessAbstract
Mucus is a viscoelastic and adhesive gel that protects the lung airways, gastrointestinal (GI) tract, vagina, eye and other mucosal surfaces. Most foreign particulates, including conventional particle-based drug delivery systems, are efficiently trapped in human mucus layers by steric obstruction and/or adhesion. Trapped particles are typically removed from the mucosal tissue within seconds to a few hours depending on anatomical location, thereby strongly limiting the duration of sustained drug delivery locally. A number of debilitating diseases could be treated more effectively and with fewer side effects if drugs and genes could be more efficiently delivered to the underlying mucosal tissues in a controlled manner. This review first describes the tenacious mucus barrier properties that have precluded the efficient penetration of therapeutic particles. It then reviews the design and development of new mucus-penetrating particles that may avoid rapid mucus clearance mechanisms, and thereby provide targeted or sustained drug delivery for localized therapies in mucosal tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiology of the Gastrointestinal Tract
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-088394-3.x5000-4 · Cited by 4,597
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · cited 2×
“Polyethylene glycol (PEG) is an uncharged hydrophilic polymer routinely used in pharmaceutics to improve systemic circulation and minimize opsonization [4,174].”
BackgroundEffect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Cited by
Items 101–124 of 124
Advances in ophthalmic drug delivery
Morrison, P. W., & Khutoryanskiy, V. V. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.75 · Cited by 196
Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide
Qiu, Y., Man, R. C. H., Liao, Q., Kung, K. L. K., Chow, M. Y. T., & Lam, J. K. W. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.026 · Cited by 178
Polymeric micelles in mucosal drug delivery: challenges towards clinical translation
Sosnik, A., & Menaker Raskin, M. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.01.003 · Cited by 154
Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease
Xiao, B., & Merlin, D. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.730517 · Cited by 145
Size-Limited Penetration of Nanoparticles into Porcine Respiratory Mucus after Aerosol Deposition
Murgia, X., Pawelzyk, P., Schaefer, U. F., Wagner, C., Willenbacher, N., & Lehr, C.-M. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b00164 · Cited by 144
Alderete, T. L., Jones, R. B., Chen, Z., Kim, J. S., Habre, R., Lurmann, F., Gilliland, F. D., & Goran, M. I. (2018) · Environmental Research · doi:10.1016/j.envres.2017.11.046 · Cited by 139
Nanodelivery in airway diseases: Challenges and therapeutic applications
Roy, I., & Vij, N. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.07.001 · Cited by 137
Protein nanocages that penetrate airway mucus and tumor tissue
Huang, X., Chisholm, J., Zhuang, J., Xiao, Y., Duncan, G., Chen, X., Suk, J. S., & Hanes, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705407114 · Cited by 131
Self-citationThe formulation of nanomedicines for treating tuberculosis
Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123
Oral delivery of peptides and proteins using lipid-based drug delivery systems
Li, P., Nielsen, H. M., & Müllertz, A. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.717068 · Cited by 116
How do polymeric micelles cross epithelial barriers?
Pepić, I., Lovrić, J., & Filipović-Grčić, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.04.012 · Cited by 102
Kim, M., Shin, M., Zhao, Y., Ghosh, M., & Son, Y. (2024) · Small Science · doi:10.1002/smsc.202400280 · Cited by 97
Suk, J. S., Boylan, N. J., Trehan, K., Tang, B. C., Schneider, C. S., Lin, J.-M. G., Boyle, M. P., Zeitlin, P. L., Lai, S. K., Cooper, M. J., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.160 · Cited by 94
Self-citationZhong, Q., Bielski, E. R., Rodrigues, L. S., Brown, M. R., Reineke, J. J., & da Rocha, S. R. P. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00126 · Cited by 88
Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases
Vij, N., Min, T., Bodas, M., Gorde, A., & Roy, I. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.06.008 · Cited by 85
Advanced nanodelivery platforms for topical ophthalmic drug delivery
Gholizadeh, S., Wang, Z., Chen, X., Dana, R., & Annabi, N. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.027 · Cited by 65
Recent developments of nanoparticle-delivered dosage forms for buccal delivery
Tran, P. H. L., Duan, W., & Tran, T. T. D. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118697 · Cited by 51
Di Cola, E., Cantu’, L., Brocca, P., Rondelli, V., Fadda, G. C., Canelli, E., Martelli, P., Clementino, A., Sonvico, F., Bettini, R., et al. (2019) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2019.110439 · Cited by 36
Song, Y. W., Nam, J., Kim, J., Lee, Y., Choi, J., Min, H. S., Yang, H., Cho, Y., Hwang, S., Son, J., et al. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122976 · Cited by 33
Tahara, K. (2020) · Advanced Powder Technology · doi:10.1016/j.apt.2019.10.031 · Cited by 31
Nucleic acid therapies for cystic fibrosis
Sasaki, S., & Guo, S. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0696 · Cited by 24
Barouei, J., Moussavi, M., & Hodgson, D. M. (2015) · Beneficial Microbes · doi:10.3920/bm2013.0011 · Cited by 18
Badten, A. J., Oaxaca-Torres, S., Basu, R. S., Gagnon, M. G., & Torres, A. G. (2025) · npj Vaccines · doi:10.1038/s41541-025-01246-2 · Cited by 4
From nature to medicine: snail slime-based functional excipients for oral dosage forms
Cabibbo, M., Scialabba, C., Drago, S. E., Craparo, E. F., & Cavallaro, G. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125914 · Cited by 3
Metadata
- Authors
- Lai, S. K., Wang, Y.-Y., & Hanes, J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 61
- Issue
- 2
- Pages
- 158-171
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1994294415
- Cited by
- 1,815
- References
- 204
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.